1. Home
  2. OSBC vs CSTL Comparison

OSBC vs CSTL Comparison

Compare OSBC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSBC
  • CSTL
  • Stock Information
  • Founded
  • OSBC 1981
  • CSTL 2007
  • Country
  • OSBC United States
  • CSTL United States
  • Employees
  • OSBC N/A
  • CSTL N/A
  • Industry
  • OSBC Major Banks
  • CSTL Medical Specialities
  • Sector
  • OSBC Finance
  • CSTL Health Care
  • Exchange
  • OSBC Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • OSBC 708.1M
  • CSTL 568.2M
  • IPO Year
  • OSBC N/A
  • CSTL 2019
  • Fundamental
  • Price
  • OSBC $14.78
  • CSTL $21.51
  • Analyst Decision
  • OSBC Buy
  • CSTL Strong Buy
  • Analyst Count
  • OSBC 5
  • CSTL 6
  • Target Price
  • OSBC $20.80
  • CSTL $40.00
  • AVG Volume (30 Days)
  • OSBC 243.3K
  • CSTL 330.2K
  • Earning Date
  • OSBC 04-23-2025
  • CSTL 05-05-2025
  • Dividend Yield
  • OSBC 1.62%
  • CSTL N/A
  • EPS Growth
  • OSBC N/A
  • CSTL N/A
  • EPS
  • OSBC 1.87
  • CSTL 0.62
  • Revenue
  • OSBC $271,799,000.00
  • CSTL $332,069,000.00
  • Revenue This Year
  • OSBC $17.44
  • CSTL N/A
  • Revenue Next Year
  • OSBC $14.38
  • CSTL $3.34
  • P/E Ratio
  • OSBC $7.90
  • CSTL $34.69
  • Revenue Growth
  • OSBC 0.81
  • CSTL 51.09
  • 52 Week Low
  • OSBC $13.26
  • CSTL $16.97
  • 52 Week High
  • OSBC $19.46
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • OSBC 33.84
  • CSTL 56.26
  • Support Level
  • OSBC $14.34
  • CSTL $18.03
  • Resistance Level
  • OSBC $15.22
  • CSTL $20.77
  • Average True Range (ATR)
  • OSBC 0.75
  • CSTL 1.27
  • MACD
  • OSBC -0.03
  • CSTL 0.41
  • Stochastic Oscillator
  • OSBC 23.19
  • CSTL 93.06

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: